Litcius/Paper detail

Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis

Manila Hada, Andrew D. Mosholder, Kira Leishear, Silvia Pérez-Vilar

2022Neurological Sciences19 citationsDOIOpen Access PDF

Topics & Concepts

MedicineObservational studyMultiple sclerosisMEDLINECoronavirus disease 2019 (COVID-19)Intensive care medicineDiseaseInternal medicineInfectious disease (medical specialty)ImmunologyLawPolitical scienceSARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis | Litcius